Prevention of cold ischaemia-reperfusion injury by an endothelin receptor antagonist in experimental renal transplantation

Nephrology Dialysis Transplantation

Volumn 14, Issue 4, 1999, Pages 872-880

  Herrero, Immaculada ^a   Torras, Joan ^a,b   Riera, Marta ^a   Condom, Enric ^b   Coll, Olga ^a   Cruzado, Josep Maria ^a,b   Hueso, Miguel ^a,b   Bover, Jordi ^a,b   Lloberas, Nuria ^a   Alsina, Jeroni ^a,b   Grinyó, Josep Maria ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Ciutat Sanitaria Universitaria B   (Spain)

Author keywords

Cold ischaemia reperfusion injury; Endothelin; ET(A) ET(B) receptor antagonist; Rat renal transplantation

Indexed keywords

BOSENTAN; CREATININE; ENDOTHELIN; ENDOTHELIN RECEPTOR ANTAGONIST; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; COLD; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; GENE EXPRESSION; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY TRANSPLANTATION; MALE; NEPHRECTOMY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; TISSUE LEVEL;

EID: 0032945189     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/14.4.872     Document Type: Article

References (43)

1. Troppmann R, Gillingham KJ, Benedetti E et al. Delayed graft function, acute rejection and outcome after cadaver renal transplantation. The multivariate analysis. Transplantation 1995; 59: 962-968
2. Moreso F, Gallen M, Garcia-Osuna R et al. Multivariate analysis of prognostic factors in renal transplantation. Transplant Proc 1995; 27: 2226-2228
3. Hakim RM, Wingard RL, Parker RA. Effect of the dialysis membrane in the treatment of patients with acute renal failure. N Engl J Med 1994; 331: 1338-1342
4. Paller MS, Hoidal JR, Ferris TF. Oxygen free radicals in ischaemic acute renal failure in the rat. J Clin Invest 1984; 74: 1156-1162
5. Torras J, Serón D, Herrero I et al. Renal protective effect of liposomed superoxide dismutase in an experimental warm ischemic model. Transplant Int 1994; 7 (Suppl. 1): S472-S475
6. Riera M, Torras J, Herrero I et al. Neutrophils accentuate renal cold ischemia reperfusion injury, role of PAF and beneficial effect of a PAF antagonist. J Pharmacol Exp Ther 1997; 280: 786-794
7. Torras J, Bordalba JR, Serón D et al. Protective effect of the PAF antagonist, BN 52021, in an experimental renal warm ischemia model. Transplant Int 1993; 6: 236-238
8. Lefer AM, Lefer DJ. Pharmacology of the endothelium in ischemia repcrfusion and circulatory shock. Annu Rev Pharmacol Toxicol 1993; 33: 71-90
9. Simonson MS, Endothelins: multifunctional renal peptides. Physiol Rev 1993; 73: 375-411
10. Watschinger B, Sayegh MH. Endothelin in organ transplantation. Am J Kidney Dis 1996; 27: 151-161
11. B endothelin antagonist, L-754142, after aortic cross-clamping in the dog. J Am Soc Nephrol 1997; 8: 1061-1071
12. Espinosa G, Lopez-Farre A, Cernadas R et al. Role of endothelin in the pathophysiology of renal ischemia reperfusion in normal rabbits. Kidney Int 1996; 50: 776-782
13. Yamada K, Hishikawa E, Kashiwabara H, Sakamoto K, Yokoyama T. Possible involvement of endothelin in posttransplant acute tubular necrosis. I. Studies in rats. Transplantation 1993; 57: 1140-1141
14. Nambi P, Pullen M, Jugus M, Gellai M. Rat kidney endothelin receptors in ischemia-induced acute renal failure. J Pharmacol Exp Ther 1993; 264: 345-348
15. Lopez-Farre A, Gomez Garre D, Bernabeu F, Lopez Novoa JM. A role for endothelin in the maintenance of postischemic renal failure in the rat. J Physiol 1991; 444: 513-522
16. Kon V, Yoshioka T, Fogo A, Ichikawa I. Glomerular actions of endothelin in vivo. J Clin Invest 1989; 83: 1762-1767
17. Gellai M, Jugus M, Fletcher T, DeWolf R, Nambi P. Reversal of postischemic acute renal failure with a selective endothelin A receptor antagonist in the rat. J Clin Invest 1994; 93: 900-906
18. Gellai M, Juglis M, Fletcher T et al. Nonpeptide endothelin receptor antagonists V: prevention and reversal of acute renal failure in the rat by SB 209670. J Pharmacol Exp Ther 1995; 275: 200-206
19. Gianello P, Fishbein J, Besse T et al. Measurement of the vasoconstrictive substances endothelin, angiotensin II and thromboxane B, in cold storage solution can reveal previous renal ischemic insults. Transplant Int 1994; 7: 11-16
20. Yamada K, Gunji Y, Hishikawa E et al. Possible involvement of endothelin in posttransplant acute tubular necrosis. I. Studies in renal transplant patients. Transplantation 1993; 57: 1137-1139
21. A) receptor antagonist, prevents ischemia reperfusion injury in kidney transplantation. Transplant Int 1996; 9: 201-207
22. Rossini M, Belloni A, Remuzzi G, Perico N. Thromboxane receptor blockade attenuates the toxic effect of cyclosporine in experimental renal transplantation. Circulation 1990; 81 (Suppl. 1): 61-67
23. Yilmaz S, Paavonen T, Häyry P. Chronic rejection of rat renal allografts, II. The impact of prolonged ischemia time on transplant histology. Transplantation 1992; 53: 823-827
24. Diamond JR, Tilney NL, Frye J et al. Progressive albuminuria and glomerulosclerosis in a rat model of chronic renal allograft rejection. Transplantation 1992; 54: 710-716
25. Leivas A, Jimenez W, Lamas S et al. Endothelin 1 does not play a major role in the homeostasis of arterial pressure in cirrhotic rats with ascites. Gastroenterology 1995; 108: 1842-1848
26. Chomczynski P, Sacchi N. Single-step method for RNA isolation by acid guanidinium thiocyanate phenol chloroform extraction. Analyt Biochem 1987; 162: 156-159
27. Sventek P, Li J, Grove K, Deschepper C, Schiffrin E. Vascular structure and expression of endothelin-1 in L-NAME-treated spontaneously hypertensive rats. Hypertension 1996; 27: 49-55
28. Firth JD, Ratcliffe PJ. Organ distribution of the three rat endothelin messenger RNAs and the effects of ischemia on renal gene expression. J Clin Invest 1992; 90: 1023-1031
29. Mimo N, Kobayashi M, Nakajima A et al. Protective effect of a selective endothelin receptor antagonist, BQ-123, in ischemic acute renal failure in rats. Eur J Pharmacol 1992; 221: 77-83
30. Kusumoto K, Kubo K, Kandori H et al. Effects of a new endothelin antagonist, TAK-044, on post-ischemic acute renal failure in rats. Life Sci 1994; 55: 301-310
31. Conger J, Robinette J, Villar A, Raij J, Schultz P. Increased nitric oxide synthase activity despite lack of response to endothelium-dependent vasodilators in postischemic acute renal failure. J Clin Invest 1995; 96: 631-638
32. Alejandro V, Scanding JD, Sibley RK et al. Mechanisms of filtration failure during postischemic injury of the human kidney. J Clin Invest 1995; 95: 820-831
33. Tomita K, Ujiie K, Nakanishi T et al. Plasma endothelin levels in patients with acute renal failure. N Engl J Med 1989; 321: 1127
34. Shibouta Y, Suzuki N, Shino H et al. Pathophysiological role of endothelin in acute renal failure. Life Sci 1990; 46: 1611-1618
35. Gellai M, DeWolf R, Pullen M, Nambi P. Distribution and functional role of renal ET receptor subtypes in normotensive and hypertensive rats. Kidney Int 1996; 46: 1287-1294
36. Brooks DP, DePalma PD, Pullen M, Nambi P. Characterization of canineendothelin receptor subtypes and their function. J Pharmacol Exp Ther 1994; 268: 1091-1097
37. Brooks DP, DePalma PD, Gellai M et al. Nonpeptide endothelin receptor antagonist: III. Effect of SB 209670 and BQ 123 on acute renal failure in anesthetized dogs. J Pharmacol Exp Ther 1994; 271: 769-775
38. Kaasjager KAH, Shaw S, Koomans HA, Rabelink TJ. Role of endothelin receptor subtypes in the systemic and renal responses to endothelin-1 in humans. J Am Soc Nephrol 1997; 8: 32-39
39. B receptors in rats. Biochem Biophys Res Commun 1994; 199: 1461-1465
40. Haynes WG, Ferro CJ, O'Kane KP, Somerville D, Lomax CC, Webb DJ. Systemic endothelin receptor blockade decreases peripheral vascular ressistance and blood pressure in humans. Circulation 1996; 93: 1860-1870
41. Wang QD, Li XS, Lundberg JM, Pernow J. Protective effects of non-peptide endothelin receptor antgonist bosentan on myocardial ischaemic and reperfusion injury in the pig. Cardiovasc Res 1995; 29: 805-812
42. B receptors in local clearance of endothelin-1 in rat heart studies with the antagonits PD 155080 and BQ-788. FEBS Lett 1996; 396: 238-242
43. Krum H, Viskoper RJ, Lacourciere Y, Budde M, Charlon V, for the Bosentan Hypertension Investigators. The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. N Engl J Med 1998; 338: 784-790